|
業務類別
|
Biotechnology |
|
業務概覽
|
Korsana Biosciences Inc is a biopharmaceutical company developing therapeutics to treat neurodegenerative diseases beginning with Alzheimer's disease (AD. The company's flagship product candidate, KRSA-028, is an anti-amyloid beta antibodythat combines the proprietary Therapeutic Targeting (THETA) platform with well-validated aspects from other anti-Ab products that have achieved regulatory approval or are in late-stage clinical trials. |
| 公司地址
| 203 Crescent Street, Buildings 3/3A/4, Suite 503, Waltham, MA, USA, 02453 |
| 電話號碼
| +1 781 516-2325 |
| 傳真號碼
| +1 617 890-6595 |
| 公司網頁
| https://www.korsana.com |
| 員工數量
| 19 |
| Dr. Jonathan Violin, M.B.A.,PhD |
Chief Executive Officer, President and Director |
-- |
09/06/2026 |
| Dr. Mark J. Vignola, PhD |
Chief Financial Officer |
-- |
09/06/2026 |
| Ms. Madelyn Zeylikman |
General Counsel and Secretary |
-- |
09/06/2026 |
| Dr. Matthew James Leoni, M.D. |
Chief Medical Officer |
-- |
11/09/2026 |
|
|
| Ms. Heidi Henson, C.P.A. |
Independent Director |
11/09/2026 |
| Dr. Jonathan Violin, M.B.A.,PhD |
Chief Executive Officer, President and Director |
09/06/2026 |
| Mr. Tomas Kiselak |
Independent Director |
11/09/2026 |
| Mr. Nimish Shah |
Independent Director |
11/09/2026 |
| Dr. Andrew Gottesdiener, M.D. |
Independent Director |
09/06/2026 |
| Ms. Michelle Patricia Pernice |
Independent Director |
09/06/2026 |
|
|
|
|
